Evolving Strategies in Adjuvant HER2+ Breast Cancer : vimars

Experts analyze adjuvant therapy based on preoperative responses. The discussion unveils standard practices, recent KATHERINE trial data, and considerations for residual disease, offering profound insights into tailoring treatment for improved outcomes.

Related Keywords

Priyanka Sharma , Joyce Oshaughnessy , Heather Mcarthur , Claudine Isaacs , Peer Exchange , Joyceo Shaughnessy , Patients , Positive , Tumors , Neoadjuvant , Adjuvant Setting , Disease , Regimen , Preoperative , Iitdm , Cancer , Negative , , Pcr , Therapy , Trial , Centimeter , Nccn Guidelines , Treatment , Data , Neoadjuvant Therapy , Adjuvant Therapy ,